Literature DB >> 14659664

Avascular necrosis of the femoral head in a HIV-1 infected patient receiving lopinavir/ritonavir.

Marco Bongiovanni1, Elisabetta Chiesa, Agostino Riva, Antonella d'Arminio Monforte, Teresa Bini.   

Abstract

The wide use of protease inhibitors (PI) as part of a highly active antiretroviral (HAART) regimen is associated with the development of several side effects. Among these, the development of avascular necrosis (AVN) of the bone is being reported more frequently and it has been related both to the use of PI and to HIV-1 infection itself. We report here a case of AVN of the bone in a patient taking the new PI lopinavir (LPV)/ritonavir (RTV) as part of a HAART regimen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14659664     DOI: 10.1016/j.ijantimicag.2003.05.006

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  3 in total

Review 1.  HIV and its effects on bone: a primer for rheumatologists.

Authors:  Lydia Gedmintas; Daniel H Solomon
Journal:  Curr Opin Rheumatol       Date:  2012-09       Impact factor: 5.006

2.  Avascular necrosis and protease inhibitors.

Authors:  Ramani Reddy; Monika N Daftary; Robert Delapenha; Arjun Dutta; Jacquay Oliver; Winston Frederick
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

3.  Rheumatic diseases in HIV-infected patients in the post-antiretroviral therapy era: a tertiary care center experience.

Authors:  Konstantinos Parperis; Yasir Abdulqader; Robert Myers; Bikash Bhattarai; Muhsen Al-Ani
Journal:  Clin Rheumatol       Date:  2018-04-04       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.